Literature DB >> 2452897

Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells.

G H Cohen1, W C Wilcox, D L Sodora, D Long, J Z Levin, R J Eisenberg.   

Abstract

Glycoprotein D (gD) is a viron envelope component of herpes simplex virus types 1 and 2. We have previously defined seven monoclonal antibody (MAb) groups which recognize distinct epitopes on the mature gD-1 protein of 369 amino acids. MAb groups VII, II, and V recognize continuous epitopes at residues 11-19, 272-279, and 340-356, respectively. MAb groups I, III, IV, and VI recognize discontinuous epitopes. Recent studies have focused on epitopes I, III, and VI. Using truncated forms of gD generated by recombinant DNA methods and proteolysis, epitopes III, IV, and VI were located within amino acids 1-233. A portion of discontinuous epitope I was located in a region within residues 233-275. For this study, we used recombinant DNA methods to create mutations in the gD-1 gene and studied the effects of those mutations on gD as expressed in mammalian cells. Plasmid pRE4, containing the coding sequence of gD-1 and the Rous sarcoma virus long terminal repeat promoter, was transfected into mammalian cells. The expressed protein, gD-1-(pRE4), was identical in size and antigenic properties to gD-1 from infected cells. Six in-frame deletion mutations were subsequently constructed by using restriction enzymes to excise portions of the gD-1 gene. Plasmids carrying these mutated forms were transfected into cells, and the corresponding proteins were examined at 48 h posttransfection for antigenicity and glycosylation patterns. Three deletions of varying size were located downstream of residue 233. Analysis of these mutants showed that amino acids within the region 234-244 were critical for binding of DL11 (group I), but not for other MAb groups. Three other deletion mutants lost all ability to bind MAbs which recognize discontinuous epitopes. In addition, much of the gD expressed by these mutants was observed to migrate as high-molecular-weight aggregated forms in nondenaturing gels. Each of these mutations involved the loss of a cysteine residue, suggesting that disulfide linkages play an essential role in the formation of discontinuous epitopes. The extent of glycosylation of the mutant gD molecules accumulated at 48 h posttransfection suggested altered carbohydrate processing. In one case, there was evidence for increased O-linked glycosylation. Those proteins which had lost a cysteine residue as part of the deletion did not accumulate molecules processed beyond the high-mannose stage. The results suggest that carbohydrate processing during synthesis of gD is very sensitive to alterations in structure, particularly changes involving cysteine residues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452897      PMCID: PMC253276     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Purification and characterization of an endo-beta-galactosidase produced by Diplococcus pneumoniae.

Authors:  S Takasaki; A Kobata
Journal:  J Biol Chem       Date:  1976-06-25       Impact factor: 5.157

2.  Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1.

Authors:  R J Eisenberg; C Hydrean-Stern; G H Cohen
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of "surface-simulation" synthesis--a powerful new concept for protein binding sites.

Authors:  M Z Atassi
Journal:  Immunochemistry       Date:  1978-12

5.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

6.  Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1.

Authors:  G H Cohen; D Long; R J Eisenberg
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

7.  Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2.

Authors:  R J Eisenberg; M Ponce de Leon; G H Cohen
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

8.  Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.

Authors:  G H Cohen; M Katze; C Hydrean-Stern; R J Eisenberg
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D.

Authors:  W C Wilcox; D Long; D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more
  56 in total

1.  Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry.

Authors:  D Shukla; M C Dal Canto; C L Rowe; P G Spear
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity.

Authors:  M I Muggeridge; W C Wilcox; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides.

Authors:  D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein.

Authors:  D L Sodora; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.

Authors:  Marcio O Lasaro; Nia Tatsis; Scott E Hensley; J Charles Whitbeck; Shih-Wen Lin; John J Rux; E John Wherry; Gary H Cohen; Roselyn J Eisenberg; Hildegund C Ertl
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

6.  Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator.

Authors:  A H Rux; S H Willis; A V Nicola; W Hou; C Peng; H Lou; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains.

Authors:  V Feenstra; M Hodaie; D C Johnson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.

Authors:  D L Sodora; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans.

Authors:  Karthigayan Gunalan; Eugenia Lo; Jessica B Hostetler; Delenasaw Yewhalaw; Jianbing Mu; Daniel E Neafsey; Guiyun Yan; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

10.  The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2.

Authors:  Francesca Cocchi; Laura Menotti; Valentina Di Ninni; Marc Lopez; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.